Conversations with Innovators: Joseph Connors, MD, on Targeted Therapy for Hodgkin Lymphoma
505 views · Published 4 September 2018 · 6:09 · Indexed 28 September 2026
Channel: American Society of Hematology · 2018 · Nonprofits & Activism
Dr. Conner discusses the Phase 3 Echelon-1 Study on targeted therapy for patients with Hodgkin Lymphoma. Visit http://www.hematology.org/Thehematologist for more videos, podcasts, and articles related to cutting-edge hematology research and practice.
More from this channel
-
1:52
Ron Reagan Accepts ASH Award - Stem Cell Research
-
3:56
ASH and the Reagans Support Stem Cell Research
-
5:17
James George Receives 2012 Wallace H. Coulter Award for Lifetime Achievement in Hematology
-
3:41
Advances in Hematology: Robert S. Negrin, MD
-
6:35
ASH News TV: Late Breaking Abstracts & ASH SAP 5th Addition
-
2:34
ASH State-of-the-Art Symposium
-
5:45
ASH News TV: Best of ASH
-
3:42
CLL-IPI: A New and Improved Staging System for CLL?